Various laboratory biomarkers have been studied in inflammatory bowel disease as diagnostic aids, indicators of disease activity or severity and to predict the risk of relapse in those patients in remission. Calprotectin, a calcium binding leukocyte-derived protein accounting for 60% in the cytosol of neutrophil leukocytes, is considered a biomarker of bowel inflammation, such as Crohn's disease and ulcerative colitis, in adults and children. It has an extremely stability in faeces, thus rendering suitable the assessment of protein in stool samples. The aim of this article is to describe biochemical, analytical and clinical findings of this marker of intestinal inflammation.
La Calprotectina nella malattia infiammatoria e nel cancro del colon / A. Barassi, G.V. Melzi d'Eril. - In: LA RIVISTA ITALIANA DELLA MEDICINA DI LABORATORIO. - ISSN 1825-859X. - 4:2(2008), pp. 104-108.
La Calprotectina nella malattia infiammatoria e nel cancro del colon
A. BarassiPrimo
;G.V. Melzi d'Eril
2008
Abstract
Various laboratory biomarkers have been studied in inflammatory bowel disease as diagnostic aids, indicators of disease activity or severity and to predict the risk of relapse in those patients in remission. Calprotectin, a calcium binding leukocyte-derived protein accounting for 60% in the cytosol of neutrophil leukocytes, is considered a biomarker of bowel inflammation, such as Crohn's disease and ulcerative colitis, in adults and children. It has an extremely stability in faeces, thus rendering suitable the assessment of protein in stool samples. The aim of this article is to describe biochemical, analytical and clinical findings of this marker of intestinal inflammation.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.